Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 5/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30741240 | 1.00 | KIF11 (0.34) | KIF11KDM1ACES2GLAPOLB | |
| Tetrafluoroethylene SCHEMBL8463376 | 0.91 | KIF11 (0.34) | KIF11CES2 | |
| SCHEMBL25791363 | 0.84 | KIF11 (0.32) | KIF11 | |
| SCHEMBL4215888 | 0.83 | — | — | |
| Piperidine SCHEMBL6382431 | 0.82 | ALDH1A1 (0.33) | — | |
| SCHEMBL24743369 | 0.79 | KIF11 (0.32) | KIF11 | |
| SCHEMBL8702494 | 0.79 | CES2 (0.32) | CES2 | |
| SCHEMBL5139030 | 0.79 | — | — | |
| SCHEMBL3257911 | 0.79 | — | — | |
| SCHEMBL465082 | 0.77 | KIF11 (0.34) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117239231-A | Electrolyte additive for lithium battery, electrolyte and preparation method of electrolyte | 哈尔滨工业大学 | 2023-12-15 | — | — | CN | claimed |
| US-6114590-A | Process for the preparation of polyhalogenated benzotrifluorides, benzotrichlorides and benzoyl chlorides and new trihalogenobenzotrichlorides and -benzoyl chlorides | BAYER AKTIENGESELLSCHAFT (DE) | 2000-09-05 | — | — | US | claimed |
| EP-0781747-B1 | Process for the preparation of 2,3,4,5-tetrafluoro-benzotrifluoride | BAYER AG (DE) | 1999-09-01 | — | — | EP | claimed |
| EP-0781747-A1 | Process for the preparation of 2,3,4,5-tetrafluoro-benzotrifluoride | BAYER AG (DE) | 1997-07-02 | — | — | EP | claimed |
| EP-0607824-A2 | Method for the production of multiply halogenated benzotrifluorides, benzotrichlorides and benzoyl chlorides as well as trihalobenzotrichlorides and -benzoyl chlorides | BAYER AG (DE) | 1994-07-27 | — | — | EP | claimed |
| JP-8231446-A | — | — | None | — | — | JP | disclosed |
| JP-6279357-A | — | — | None | — | — | JP | disclosed |
| US-12559454-B2 | Benzenesulfonamide derivatives and uses thereof | 2692372 ONTARIO, INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| CN-118160076-B | Etching gas and etching method using the same | 大金工业株式会社 | 2024-08-27 | — | — | CN | disclosed |
| CN-118160076-A | Etching gas and etching method using the same | 大金工业株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-20240092756-A1 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | DUNAD THERAPEUTICS LTD. (GB) | 2024-03-21 | — | — | US | disclosed |
| US-20240018153-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO, INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| EP-0453842-A2 | Fluor subsituted derivatives of alpha-(5-aryloxy-naphthalen-1-yloxy)propionic acid | BAYER AG (DE) | 1991-10-30 | — | — | EP | disclosed |
| US-5030252-A | Polytarylene ethers; permselectivity | THE DOW CHEMICAL COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0416365-A2 | Carbocyclic anilide derivatives | BAYER AG (DE) | 1991-03-13 | — | — | EP | disclosed |
| EP-0416359-A1 | Carbocyclic anilide carbamates | BAYER AG (DE) | 1991-03-13 | — | — | EP | disclosed |
| EP-0339418-A2 | Substituted anilides of the cycloalkyl- or heterocyclyl-carboxylic acids | BAYER AG (DE) | 1989-11-02 | — | — | EP | disclosed |
| US-4868347-A | SOLVENT EXTRACTION | BAYER AKTIENGESELLSCHAFT (DE) | 1989-09-19 | — | — | US | disclosed |
| EP-0270964-A2 | Process for obtaining substituted fluorobenzenes | BAYER AG (DE) | 1988-06-15 | — | — | EP | disclosed |
| US-4038276-A | PROCESS FOR THE PRODUCTION OF FINELY DIVIDED SOLID CYANURIC CHLORIDE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092756-A1 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | KRAS, NRAS, HRAS | KIF11 2167/4885KDM1A 3061/4885CES2 4841/4885 |
| US-12559454-B2 | Benzenesulfonamide derivatives and uses thereof | NR2E1, NR2C2, NR3C1 | KIF11 4365/4885KDM1A 4598/4885CES2 2247/4885 |
| US-20240018153-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | ABCG2, ABCB1, ARSA | KIF11 3174/4885KDM1A 3006/4885CES2 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.